重症流感患者流感相关肺曲霉病的患病率、危险因素、临床特征与结局:系统评价与Meta分析
该系统评价与Meta分析纳入10项观察性研究、共1720例重症流感患者,流感相关肺曲霉病(IAPA)患病率为19.2%(331/1720)。器官移植、血液系统恶性肿瘤、免疫抑制及入院前长期使用糖皮质激素与IAPA风险升高相关,IAPA患者ICU死亡率显著升高(OR 2.6,95%CI 1.8-3.8)。
要点
- 重症流感患者中IAPA患病率约19.2%,应视为常见并发症。
- 器官移植、血液肿瘤、免疫抑制及长期激素使用是IAPA危险因素。
- IAPA与更重病情、更多并发症、更长ICU停留及更高ICU死亡率相关。
核心结论
- IAPA是重症流感的常见并发症,与死亡率升高相关。
- 早期诊断IAPA并启动抗真菌治疗至关重要。
- 未来研究应聚焦于开发临床算法。
研究设计与样本
- 系统评价与Meta分析,检索PubMed MEDLINE、CINAHL、Cochrane Library、Embase、Scopus、Cochrane Trials及ClinicalTrials.gov。
- 纳入10项观察性研究,共1720例重症流感患者。
- 采用随机效应模型对危险因素、临床特征、发病率及死亡率进行单组Meta分析。
主要发现
- IAPA患病率为19.2%(331/1720)。
- 器官移植者IAPA风险升高(OR 4.8;95%CI 1.7-13.8;I2=45%)。
- 血液系统恶性肿瘤者IAPA风险升高(OR 2.5;95%CI 1.5-4.1;I2=0%)。
- 免疫抑制者IAPA风险升高(OR 2.2;95%CI 1.6-3.1;I2=0%)。
- 入院前长期使用糖皮质激素者IAPA风险升高(OR 2.4;95%CI 1.4-4.3;I2=51%)。
关键数值与推荐
- IAPA与ICU死亡率升高显著相关(OR 2.6;95%CI 1.8-3.8;I2=0%)。
- 常见临床与影像特征与IAPA无特别关联。
- IAPA与更严重的疾病进展、更高的并发症发生率、更长的ICU停留及更多器官支持需求相关。
临床怎么用
- 对重症流感患者应警惕IAPA,尤其存在器官移植、血液肿瘤、免疫抑制或长期激素使用史者。
- 早期诊断IAPA并尽早启动抗真菌治疗。
局限性
- 纳入研究均为观察性研究。
- 部分危险因素分析存在中度异质性(如器官移植I2=45%、长期激素使用I2=51%)。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Influenza-associated pulmonary aspergillosis (IAPA) increasingly is being reported in critically ill patients. We conducted this systematic review and meta-analysis to examine the prevalence, risk factors, clinical features, and outcomes of IAPA. STUDY QUESTION: What are the prevalence, risk factors, clinical features, and outcomes of IAPA in critically ill patients? STUDY DESIGN AND METHODS: Studies reporting IAPA were searched in the following databases: PubMed MEDLINE, CINAHL, Cochrane Library, Embase, Scopus, Cochrane Trials, and ClinicalTrials.gov. We performed one-group meta-analysis on risk factors, clinical features, morbidity, and mortality using random effects models. RESULTS: We included 10 observational studies with 1,720 critically ill patients with influenza, resulting in an IAPA prevalence of 19.2% (331 of 1,720). Patients who had undergone organ transplantation (OR, 4.8; 95% CI, 1.7-13.8; I2 = 45%), harbored a hematogenous malignancy (OR, 2.5; 95% CI, 1.5-4.1; I2 = 0%), were immunocompromised (OR, 2.2; 95% CI, 1.6-3.1; I2 = 0%), and underwent prolonged corticosteroid use before admission (OR, 2.4; 95% CI, 1.4-4.3; I2 = 51%) were found to be at a higher risk of IAPA developing. Commonly reported clinical and imaging features were not particularly associated with IAPA. However, IAPA was associated with more severe disease progression, a higher complication rate, and longer ICU stays and required more organ supports. Overall, IAPA was associated with a significantly elevated ICU mortality rate (OR, 2.6; 95% CI, 1.8-3.8; I2 = 0%). INTERPRETATION: IAPA is a common complication of severe influenza and is associated with increased mortality. Early diagnosis of IAPA and initiation of antifungal treatment are essential, and future research should focus on developing a clinical algorithm. TRIAL REGISTRY: International Prospective Register of Systematic Reviews; No.: CRD42022284536; URL: https://www.crd.york.ac.uk/prospero/.
引用
- Lu LY, Lee HM, Burke A, et al. Prevalence, Risk Factors, Clinical Features, and Outcome of Influenza-Associated Pulmonary Aspergillosis in Critically Ill Patients: A Systematic Review and Meta-Analysis. Chest. 2023. PMID: 37742914. doi:10.1016/j.chest.2023.09.019
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。